NSBCC: NSBCC: NanoSystems Biology Cancer Center

Luxembourg announced collaboration with NSBCC researchers to accelerate biomedical research

The Grand Duchy of Luxembourg has announced an ambitious plan to increase the pace of innovation in the areas of molecular biology, systems biology, and personalized medicine.   To achieve this goal, Luxembourg is investing $200M in three collaborations, one of which is headed by NSBCC co-director Leroy Hood.   Dr. Hood is President and Founder of the Institute for Systems Biology ( www.systemsbiology.org [1] ). 

A second collaboration is with the Partnership for Personalized Medicine (PPM).  The PPM is headed by Dr. Leland Hartwell.  Dr. Harwell won the 1991 Nobel Prize in Physiology or Medicine, and currently serves as the Director of the Fred Hutch Cancer Center in Seattle. 

A third collaboration is with The Translational Genomics Research Institute (T-Gen) of Arizona.  Dr. Jeff Trent is President and Scientific Director of T-Gen. 

The bulk of the research, for all three collaborations, will focus on cancer, and will provide significant leverage to the NSBCC. 

The collaboration led by Dr. Hood involves a number of other scientists, including Dr. David Galas, Dr. Jim Heath (NSBCC Director), and Dr. Ruedi Aebersold.  Dr. Hood, Dr. Galas, and Dr. Heath were all present in Luxembourg for the announcement.

The other groups collaborating with Luxembourg are headed by Dr. Leland Hartwell, Nobel laureate and Director of the Fred Hutch Cancer Center in Seattle, and Dr. Jeff Trent, President and Scientific Director of the Translational Genomics Research Institute (T-Gen) in Arizona. 

The collaborations were announced on Friday, June 6 in Luxembourg.  Click here for the full press release: 

http://www.ibtimes.com/prnews/20080606/leading-u-s-bioscience-pioneers-enter-international-collaboration-with-government-of-luxembourg-to-a.htm

 


Source URL:
http://caltechcancer.org/node/260